Radiance Therapeutics' Debt Round

Radiance Therapeutics raised a round of funding on July 31, 2018.

Radiance Therapeutics is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery. Its Beta Ophthalmic System is designed to apply beta therapy to the surg…

Articles about Radiance Therapeutics' Debt Round: